SCHEMBL8822110

SCHEMBL8822110

Cc1oncc1OC(=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
HSD17B10 Q99714 1/20 0.51
GAA P10253 3/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSP90AA1 P07900 1/20 0.47
KDM4E B2RXH2 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
RAB9A P51151 4/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.43
RAD51 Q06609 1/20 0.43
NPC1 O15118 1/20 0.43
CSF1R P07333 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6932048 0.87 MAPT (0.46) ALDH1A1HSD17B10GAAHTTSMN1; SMN2
SCHEMBL6931877 0.86 THRB (0.48) GAAHTTSMN1; SMN2KDM4EBLM
SCHEMBL6937152 0.82 CA1 (0.40) HTTSMN1; SMN2BLMRAB9AATM
SCHEMBL7783570 0.82 DHODH (0.63) HTTSMN1; SMN2BLMKMT2ARAB9A
SCHEMBL6936296 0.82 RAB9A (0.39) HTTSMN1; SMN2BLMKMT2ARAB9A
SCHEMBL10643669 0.80 NPC1 (0.38) ALDH1A1HSD17B10HTTSMN1; SMN2BLM
SCHEMBL10648551 0.79 SMN1; SMN2 (0.44) ALDH1A1HTTSMN1; SMN2BLMKMT2A
SCHEMBL10646741 0.78 DHODH (0.43) HTTSMN1; SMN2BLMKMT2ARAB9A
SCHEMBL10644685 0.76 NPC1 (0.41) HTTSMN1; SMN2BLMRAB9ANPC1
SCHEMBL3650040 0.76 LMNA (0.35) ALDH1A1HSD17B10HTTSMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0413329-B1 5-Methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases ALCON LAB INC (US) 1997-02-05 EP disclosed
EP-0413329-A2 5-Methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases ALCON LABORATORIES, INC. (US) 1991-02-20 EP disclosed
EP-0013376-B1 ISOXAZOLE DERIVATIVE, PROCESS FOR ITS PREPARATION AND COMPOSITION CONTAINING IT HOECHST AKTIENGESELLSCHAFT (DE) 1982-05-19 EP disclosed